Search

everythinglearnresearchcommunity

for

Search:↓

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

The study aims to create a model to predict health attributes using diverse health data from Japanese adults.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

The study aims to create a model to improve personalized and preventive health care.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

The study found that expanded skin regenerates similarly to normal skin, with 77 genes playing a role in the process.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Finasteride may help treat kidney disease caused by a high-fat diet by reducing harmful toxins and improving gut bacteria.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.